Effects of dobutamine stimulation on myocardial blood flow, glucose metabolism, and wall motion in normal and dysfunctional myocardium

Circulation

Volumn 94, Issue 12, 1996, Pages 3146-3154

  Sun, Karl T ^c   Czernin, Johannes ^c   Krivokapich, Janine ^c   Lau, Yuk Kong ^a   Böttcher, Morten ^c   Maurer, Gerald ^a   Phelps, Michael E ^c   Schelbert, Heinrich R ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

blood flow; coronary disease; glucose; metabolism; myocardium; tomography

Indexed keywords

AMMONIA; DOBUTAMINE; FATTY ACID; FLUORODEOXYGLUCOSE F 18; GLUCOSE; INSULIN; LACTIC ACID; NITROGEN 13;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HEART DISEASE; HEART MOVEMENT; HEART MUSCLE; HEART MUSCLE BLOOD FLOW; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030481629     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.12.3146     Document Type: Article

References (38)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989; 117:211-221.
2. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M, Schelben HR. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med. 1986; 314:884-888.
3. Czernin J, Porenta G, Rosenquist G, Kuhle W, De Groof M, Krivokapich J, Brunken R, Mody F, Phelps M, Schelbert H. Loss of coronary perfusion reserve in PET ischemia. Circulation. 1991;84 (suppl II):II-47. Abstract.
4. Vanoverschelde JL J, Melin J, Bol A, Vanbutsele R, Cogneau M, Labar D, Robert A, Michel C, Wijns W. Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Circulation. 1992;85:9-21.
5. Pierard L, De Landsheere C, Berthe C, Rigo P, Kulbertus H. Identification of viable myocardium by echocardiography during dobutamine infusion in patients with myocardial infarction after thrombolytic therapy: comparison with positron emission tomography. J Am Coll Cordial. 1990;15:1021-1031.
6. La Canna G, Alfieri O, Giubbini R, Gargano M, Ferrari R, Visioli O. Echocardiograpny during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 1994;23:617-626.
7. Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, Chen K, Chan A, Phelps ME, Schelbert HR. Influence of age and hemodynamics on myoeardial blood flow and flow reserve. Circulation. 1993;88:62-69.
8. Choi Y, Brunken RC, Hawkins RA, Huang S-C, Buxton DB, Hoh CK, Phelps ME, Schelbert HR. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med. 1993;20: 308-318.
9. Kuhle W, Porenta G, Huang S-C, Phelps M, Schelbert H. Issues in the quantitation of reoriented cardiac PET images. J Nucl Med. 1992;33:1235-1242.
10. Porenta G, Kuhle W, Czernin J, Ratib O, Brunken RC, Scheiben HR. Interactive user-friendly image analysis of cardiac PET images on a low cost desktop computer. IEEE Trans Biomed Eng. 1992;33: 245-248.
11. Porenta G, Kuhle W, Czernin J, Ratib O, Brunken R, Phelps M, Scheibert H. Semiquantitative assessment of myocardial viability and perfusion utilizing polar map displays of cardiac PET images. J Nucl Med. 1992;33:1628-1636.
12. Czernin J, Porenta G, Brunken R, Krivokapich J, Chen K, Bennett R. Hage A, Fung C, Tillisch J, Phelps M, Schelbert H. Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction. Circulation. 1993;88:885-895.
13. Folland ED, Parisi AF, Moynihan PF. Assessment of left ventricular ejection fraction and volumes by real-time, two dimensional echocardiography: a comparison of cineographic and radionuclide techniques. Circulation. 1979;60:760. Abstract.
14. Czernin J, Müller P, Kim A, Chan S, Porenta G, DeGroof M. Rosenqvist G, Chan A, Phelps M, Schelbert H. Myocardial flow reserve declines with age because of higher cardiac work at rest. J Nucl Med. 1992;33:836. Abstract.
15. Ratib O, Phelps ME, Huang SC, Henze E, Selin CE, Schelbert HR. Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism. J Nucl Med. 1982;23:577-586.
16. 13N-ammonia and reoriented dynamic positron emission tomographic imaging. Circulation. 1992;86:1004-1017.
17. Choi Y, Hawkins R, Huang S, Gambhir S, Brunken R, Phelps M, Scheiben H. Parametric images of myocardial metabolic rate of glucose generated from dynamic cardiac PET and 2-[18F]fluoro-2deoxy-d-glucose studies. J Nucl Med. 1991;32:733-738.
18. Vanoverschelde J-L, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol A, Meiin JA. Mechanisms of chronic regional postischemic dysfunction in humans: new insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87: 1513-1523.
19. Maes A, Flameng W, Nuyts J, Borgers M, Shivalkar B, Ausma J, Bormans G, Schiepers C, De Roo M, Mortelmans L. Histological alterations in chronically hypoperfused myocardium. Circulation. 1994;90:735-745.
20. Depre C, Vanoverschelde JL J, Melin J, Borgers M, Bol A, Ausma J. Dion R, Wijns W. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol. 1995;268:H1265-H1275.
21. Becker LC. Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia. Circulation. 1978;57:1103-1110.
22. Liedtke AJ. Alterations of carbohydrate and lipid metabolism in the acutely ischemic heart. Prog Cardiovasc Dis. 1981;23:321-336.
23. Opie LH. Effects of regional ischemia on metabolism of glucose and fatty acids. Circ Res. 1976;38:152-174.
24. Chan A, Czernin J, Brunken R, Choi Y, Krivokapich J, Scheiben HR. Effects of fasting on the incidence of blood flow metabolism mismatches in chronic CAD patients. J Am Coll Cardiol. 1993; 21:129A. Abstract.
25. Schwaiger M, Sun D, Deeb G, Nguyen N, Haas F, Sebening F, Brosius FC. Expression of myocardial glucose transporter (GLUT) mRNAs in patients with advanced coronary artery disease (CAD). Circulation. 1994;90(suppl I):I-113. Abstract.
26. Holmberg S, Serzysko W, Varnauskas E. Coronary circulation during heavy exercise in control subjects and patients with coronary heart disease. Acta Med Scand. 1971;190:465-480.
27. Willerson JT, Hutton I, Watson JT, Platt MR, Templeton GH. Influence of dobutamine on regional myocardial blood flow and ventricular performance during acute and chronic myocardial ischemia in dogs. Circulation. 1976;53:828-833.
28. Merhige ME, Ekas R, Mossberg K, Taegtmeyer H, Could KL. Catecholamine stimulation, substrate competition, and myocardial glucose uptake in conscious dogs assessed with positron emission tomography. Circ Res. 1987;61(suppl II):II-124-II-129.
29. Bristow MR, Ginsburg R, Monobe W, Cubiciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EE. Decreased catecholamine sensitivity and B-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205-211.
30. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Circulation. 1990;81:1161-1172.
31. Tsutsui H, Ishihara K, Cooper G. Cytoskeletal role in the contractile dysfunction of hypertrophied myocardium. Science. 1993; 260:682-687.
32. Klug D, Robert V, Swynghedauw B. Role of mechanical and hormonal factors in cardiac remodeling and the biologic limits of myocardial adaptation. Am J Cardiol. 1993;71:46A-54A.
33. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation. 1993;87:755-763.
34. Chareonthaitawee P, Christian T, Hirose K, Gibbons R, Rumberger J. Relation of initial infarct size to extent of left ventricular remodeling in the year after acute myocardial infarction. J Am Cull Cardiol. 1995;25:567-573.
35. Schaper J, Froedi R, Hein S, Buck A, Hashizume H, Speiser B, Friedl A, Bleese N. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation. 1991;83: 504-514.
36. Neglia D, Parodi O, Gallopin M, Sambuceti G, Giorgetli A, Pratali L, Salvadori P, Michelassi C, Lunardi M, Pelosi G, Marzilli M, L'Abbate A. Myocardial blood How response to pacing tachycardia and to dipyridamole infusion in patients with dilated eardiomyopathy without overt heart failure. Circulation. 1995;92:796-804.
37. Krivokapich J, Huang S, Schelbert H. Assessment of the effects of dobulamine on myocardial blood flow and oxidative metabolism in normal human subjects using nitrogen-13 ammonia and carbon-11 acetate. Am J Cartliol. 1993:71:1351-1356.
38. Krivokapich J, Schelbert H, Czernin J. Dobutamine positron emission tomography: absolute quantitation of rest and dobutamine myocardial blood flow and correlation with cardiac work and percent diameter stenosis in patients with and without coronary artery disease. J Am Coll Cardiol. 1996;28:565-572.